Have your own idea? Try our Stock Screener
Over the last 7 days, the Biotech industry has risen 1.1%, driven by gains in Swedish Orphan Biovitrum and Vitrolife of 1.2% and 3.4%, respectively. In the last 12 months, the industry was up 31%. As for the next few years, earnings are expected to grow by 47% per annum.
Has the Swedish Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 10 Sep 2024 | SEK 217.6b | SEK 31.5b | -SEK 5,557,002,759.46 | 51x | -39.2x | 6.9x |
Thu, 08 Aug 2024 | SEK 193.1b | SEK 31.4b | -SEK 5,419,185,882.67 | 43x | -35.6x | 6.2x |
Sat, 06 Jul 2024 | SEK 193.3b | SEK 30.6b | -SEK 5,537,801,084.49 | 38.9x | -34.9x | 6.3x |
Mon, 03 Jun 2024 | SEK 198.9b | SEK 30.6b | -SEK 5,722,606,652.25 | 39.8x | -34.8x | 6.5x |
Wed, 01 May 2024 | SEK 185.4b | SEK 30.8b | -SEK 5,544,266,153.62 | 50.5x | -33.4x | 6x |
Fri, 29 Mar 2024 | SEK 185.1b | SEK 29.8b | -SEK 5,642,738,521.42 | 60.5x | -32.8x | 6.2x |
Sun, 25 Feb 2024 | SEK 179.4b | SEK 29.8b | -SEK 5,768,696,000.91 | 51.4x | -31.1x | 6x |
Tue, 23 Jan 2024 | SEK 187.8b | SEK 28.7b | -SEK 1,200,387,276.00 | 59x | -156.5x | 6.5x |
Thu, 21 Dec 2023 | SEK 180.6b | SEK 28.7b | -SEK 1,169,327,462.00 | 60.3x | -154.4x | 6.3x |
Sat, 18 Nov 2023 | SEK 166.9b | SEK 28.7b | -SEK 1,255,777,561.00 | 52.8x | -132.9x | 5.8x |
Mon, 16 Oct 2023 | SEK 154.5b | SEK 27.4b | -SEK 1,963,051,432.00 | 48.8x | -78.7x | 5.6x |
Wed, 13 Sep 2023 | SEK 150.5b | SEK 27.4b | -SEK 1,977,604,484.00 | 45.9x | -76.1x | 5.5x |
Fri, 11 Aug 2023 | SEK 159.0b | SEK 27.5b | -SEK 1,575,693,675.00 | 53.4x | -100.9x | 5.8x |
Sun, 09 Jul 2023 | SEK 160.8b | SEK 26.4b | -SEK 1,314,497,311.00 | 44.8x | -122.4x | 6.1x |
Tue, 06 Jun 2023 | SEK 167.6b | SEK 26.4b | -SEK 1,191,274,285.00 | 45.9x | -140.7x | 6.4x |
Thu, 04 May 2023 | SEK 175.0b | SEK 26.3b | -SEK 1,246,262,375.00 | 47.2x | -140.4x | 6.7x |
Sat, 01 Apr 2023 | SEK 167.9b | SEK 25.4b | -SEK 2,016,129,138.00 | 38x | -83.3x | 6.6x |
Mon, 27 Feb 2023 | SEK 170.0b | SEK 25.4b | -SEK 2,036,417,969.00 | 39.6x | -83.5x | 6.7x |
Wed, 25 Jan 2023 | SEK 172.3b | SEK 23.8b | -SEK 1,838,166,502.00 | 32.4x | -93.8x | 7.2x |
Fri, 23 Dec 2022 | SEK 156.7b | SEK 23.8b | -SEK 1,841,334,757.00 | 31.5x | -85.1x | 6.6x |
Sun, 20 Nov 2022 | SEK 156.9b | SEK 23.8b | -SEK 1,761,618,179.00 | 32.1x | -89.1x | 6.6x |
Tue, 18 Oct 2022 | SEK 153.0b | SEK 22.9b | -SEK 3,333,771,163.00 | 31.2x | -45.9x | 6.7x |
Thu, 15 Sep 2022 | SEK 153.0b | SEK 22.9b | -SEK 3,248,058,622.00 | 32.9x | -47.1x | 6.7x |
Sat, 13 Aug 2022 | SEK 172.6b | SEK 22.6b | -SEK 3,542,560,964.00 | 35x | -48.7x | 7.6x |
Mon, 11 Jul 2022 | SEK 164.2b | SEK 21.4b | -SEK 3,520,210,178.00 | 40.3x | -46.7x | 7.7x |
Wed, 08 Jun 2022 | SEK 157.8b | SEK 21.4b | -SEK 3,525,530,117.00 | 43.9x | -44.8x | 7.4x |
Fri, 06 May 2022 | SEK 147.3b | SEK 21.3b | -SEK 3,505,394,673.00 | 42.1x | -42x | 6.9x |
Sun, 03 Apr 2022 | SEK 175.9b | SEK 19.7b | -SEK 3,200,657,964.00 | 51.5x | -55x | 8.9x |
Tue, 01 Mar 2022 | SEK 161.5b | SEK 19.7b | -SEK 2,959,932,143.00 | 50.5x | -54.6x | 8.2x |
Thu, 27 Jan 2022 | SEK 164.6b | SEK 19.1b | -SEK 2,049,216,259.00 | 48.6x | -80.3x | 8.6x |
Sat, 25 Dec 2021 | SEK 198.8b | SEK 19.1b | -SEK 2,004,036,910.00 | 52x | -99.2x | 10.4x |
Mon, 22 Nov 2021 | SEK 204.4b | SEK 19.0b | -SEK 1,498,813,893.00 | 55.8x | -136.4x | 10.8x |
Wed, 20 Oct 2021 | SEK 200.6b | SEK 18.1b | -SEK 1,349,751,367.00 | 48.4x | -148.6x | 11.1x |
Fri, 17 Sep 2021 | SEK 217.7b | SEK 18.1b | -SEK 1,339,316,907.00 | 52.4x | -162.5x | 12x |
-162.5x
Which industries have driven the changes within the Swedish Healthcare industry?
SE Market | -2.60% | |
Healthcare | 1.07% | |
Biotech | 1.08% | |
Biotech | 1.08% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
SOBI Swedish Orphan Biovitrum | SEK 319.60 | 1.8% +SEK 1.9b | 44.6% | PE51x | |
VITR Vitrolife | SEK 258.80 | 2.9% +SEK 974.8m | 96.8% | PS9.9x | |
BIOA B BioArctic | SEK 174.80 | 5.8% +SEK 848.0m | -42.4% | PS51.6x | |
BINV BioInvent International | SEK 45.25 | 12.8% +SEK 338.9m | 180.7% | PS56.5x | |
SANION Saniona | SEK 4.95 | 14.1% +SEK 67.9m | -21.3% | PS22.1x |